Stopping MS
WFTV 9 Orlando Thu, 28 Feb 2008 12:17 PM PST
About 400,000 Americans have multiple sclerosis, a debilitating disease that causes difficult walking and an inability to control breathing. But doctors are testing a new drug that could stop the disease in its tracks. VIDEO: Stopping MS
HEALTH NOTES
Richmond Times-Dispatch Wed, 27 Feb 2008 9:24 PM PST
"Diabetic Dining Made Easy" will be offered Wednesday, and April 2 from 9:30 to 11:30 a.m. and again April 7 from 7 to 9 p.m. at VCU Women's Health Care, 9000 Stony Point Parkway. The cost is $35. Elizabeth Horn of Disability Benefits Assistance will speak at the Hanover Multiple Sclerosis Support Group meeting today at 7 p.m. at Commonwealth Wholesale Inc., 10085 Leadbetter Place, Ashland.

---

Multiple Sclerosis, Cannabinoids, and Cognition
Journal of Neuropsychiatry (subscription) - USA
79 This review also reported that chronic progressive multiple sclerosis patients display maximal deficits on frontal-executive tasks, whereas patients with ...
See all stories on this topic

---

Tysabri

Thursday Newspaper Review - Irish Business News and International ...
FinFacts Ireland - Ireland
A total of 21100 multiple sclerosis patients were being treated with Tysabri early last month. The company recently received permission from the FDA to ...
See all stories on this topic

Tysabri May Cause Significant Liver Injury
Medscape (subscription) - USA
February 27, 2008 — Significant liver injury has been reported in some patients receiving treatment with natalizumab (Tysabri, Biogen Idec, Inc), ...
See all stories on this topic

Biogen warns of liver damage risk from Tysabri Mass High Tech: The ...
Bizjournals.com - Charlotte,NC,USA
Last month, the FDA approved the Tysabri as a treatment for a chronic inflammatory condition called Crohn's disease. The treatment was previously approved ...
See all stories on this topic

Wednesday's Health Winners & Losers
TheStreet.com - USA
Biogen IdecBIIB and ElanELN lost ground after the FDA posted a letter to doctors warning about the effects of the companies' multiple sclerosis drug Tysabri ...
See all stories on this topic

Biogen's Tysabri May Cause Liver Injury, US Says (Update3)
Bloomberg - USA
s multiple sclerosis medicine Tysabri may harm the liver within six days of the first dose, US regulators said, urging doctors to warn patients about the ...
See all stories on this topic

Hepatoxicity Warning Added to Natalizumab (Tysabri) Label
MedPage Today - Little Falls,NJ,USA
27 -- The multiple sclerosis drug natalizumab (Tysabri) may cause clinically significant liver injury, which can occur as early as six days after the ...
See all stories on this topic

Shares of Biogen and Elan fall on reports of liver damage in ...
International Herald Tribune - France
The companies issued a warning to doctors that signs of liver injury appeared in patients as early as six days after first taking Tysabri. ...
See all stories on this topic

Biogen's Tysabri May Cause Liver Injury, US Says (Update2)
Bloomberg - USA
s multiple sclerosis medicine Tysabri may cause significant liver injury within six days of the first dose, US regulators said. Patients should stop taking ...
See all stories on this topic

Biogen, Elan warn of liver injury from Tysabri
Reuters - USA
Signs of liver damage occurred in some patients as early as six days after their first dose of Tysabri, the companies said in their letter. ...
See all stories on this topic

Biogen, Elan warn of liver injury risks w/Tysabri in letter posted ...
CNNMoney.com - USA
'In some patients, liver injury recurred upon rechallenge, providing evidence that Tysabri caused the injury.' Any patients exhibiting signs of jaundice or ...
See all stories on this topic

Elan's credit rating outlook raised to positive by Moody's ...
CNNMoney.com - USA
Moody's Analyst Michael Levesque said other positive developments for the drugmaker include the recent US Food and Drug Administration approval of Tysabri ...
See all stories on this topic

---

Acorda Therapeutics Q4 Loss Widens On Expenses
RTT News - Williamsville,NY,USA
We also initiated investments for the commercialization of Fampridine-SR, if approved.” As of December 31, 2007, Acorda held cash, cash equivalents and ...
See all stories on this topic

Acorda Therapeutics Announces Acquisition of Aminopyridine and Pre ...
FOXBusiness - USA
Acorda Therapeutics is a biotechnology company developing therapies for spinal cord injury, multiple sclerosis and related nervous system disorders. ...
See all stories on this topic

Novartis premium threatened by sparse new drugs
Guardian Unlimited - UK
It lacks any obvious billion-dollar seller candidates with the possible exception of FTY720 for multiple sclerosis. Chairman and Chief Executive Daniel ...
See all stories on this topic

Cytomegalovirus Infection in Paediatric Haemopoietic Stem Cell ...
Irish Medical Journal - Dublin,Ireland
The pan T-cell antibody Campath was incorporated into conditioning regimens for patients undergoing unrelated transplants. Three patients had ex vivo T-cell ...
See all stories on this topic

NeoStem Reports Positive Stem Cell Industry Research Trends From ...
Earthtimes - London,UK
... multiple sclerosis and arthritis. More than 500 of these are for autologous use, meaning the stem cells come from your own body for your own use. ...
See all stories on this topic

Acute and Chronic Lyme Disease: Controversies for Neuropsychiatry
Journal of Neuropsychiatry (subscription) - USA
Small areas of abnormality in the white matter that are hyperintense on T2W MRI, similar to those seen in multiple sclerosis, may be present. ...
See all stories on this topic

---

Chef With Multiple Sclerosis Uses Culinary Skills And Passion For Golf To Support National MS Society Michigan Chapter
Medical News Today Thu, 28 Feb 2008 2:05 AM PST
The first thing that Chef Bill Pikarski wants you to know is that Multiple Sclerosis is not a death sentence. Nor does it mean that you cannot live a full, rewarding life. After being diagnosed with MS in August of 2002, Pikarski went through a period of depression and denial. Two things helped change his outlook: The National Multiple Sclerosis Society and golf.